0% found this document useful (0 votes)
53 views21 pages

Maternal Death Review: Eclampsia Case Study

The document details the case of a 25-year-old pregnant woman, Monalisha Mohapatra, who was admitted for labor and underwent a cesarean section but subsequently experienced severe complications. Despite intensive care, she suffered from postpartum eclampsia and acute fatty liver, leading to her death two days after admission. The timeline highlights her medical history, treatment protocols, and the progression of her condition until her passing on March 19, 2025.

Uploaded by

Biswajyoti Sahu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
53 views21 pages

Maternal Death Review: Eclampsia Case Study

The document details the case of a 25-year-old pregnant woman, Monalisha Mohapatra, who was admitted for labor and underwent a cesarean section but subsequently experienced severe complications. Despite intensive care, she suffered from postpartum eclampsia and acute fatty liver, leading to her death two days after admission. The timeline highlights her medical history, treatment protocols, and the progression of her condition until her passing on March 19, 2025.

Uploaded by

Biswajyoti Sahu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd

MATERNAL DEATH

REVIEW CASE
DISCUSSION
PRESENTED BY DEPARTMENT OF OBSTERTICS AND GYNECOLOGY
FM MEDICAL COLLEGE AND HOSPITAL

DR ANKITA PRIYADRASHINI
PATIENT DETAILS:
Pt Monalisha Mohapatra w/o Jayanta Kumar Sethi 25 yrs from Soro was admitted to labor room on
16.03.2025, 7:40 PM FMMCH,under 2nd unit.

HISTORY OF PRESENT ILLNESS:


There was pain abdomen which was intermittent
H/O leaking PV since 1 day
No H/O PV bleeding or abdomen vaginal discharge
No H/O urinary symptoms

MENSTRUAL HISTORY:
Menarche-13yrs
Cycles-5-6d/28-30d, regular, average flow
LMP-15/6/24
EDD-22/3/25
GA-39 weeks
OBSTERTIC HISTORY:
Married for 5 years
G1-MCH/2.8KG/NVD/4 YEARS BACK which was uneventful
G2- spontaneous continuing

FIRST TRIMESTER:
No H/O hyperemesis gravidarum, bleeding
No H/O exposure to teratogenic drugs, radiation
T-FA taken till 14 weeks , 1 ANC visit

SECOND TRIMESTER:
2 Antenatal visit, 4 VHSND
Started IFA and calcium
Quickening at 20 weeks
Received 2 doses of Td, investigations were done
No H/O bleeding PV, no HDP
BLOOD GROUP-A+VE
VDRL, TOXOPLASMA-NEGATIVE
HIV, HBsAg, HCV-NEGATIVE
Hb-11gm%
TIFFA scan- Not done

THIRD TRIMESTER:
2 Antenatal visits, 3 VHND
Regular intake of IFA and calcium
Daily fetal movement count was good
No Bleeding PV , urinary symptoms
Hb-10.6 g/dl

PAST HISTORY:
Not a K/C/O Diabetes, HTN, Hypothyroidism, Asthma, Cardiac disease, Epilepsy, TB, Liver disease.
No H/O drug allergy
FAMILY HSITORY:
No family H/O Diabetes, HTN, Hypothyroidism, Asthma, Cardiac disease, Epilepsy, TB, Liver disease,
Malignancy

PERSONAL HISTORY:
•Rural background
•Mixed Indian average diet
•Sleep appetite- Normal
•No H/O prior contraception
•No addiction to tobacco

ON ADMISSION AT 7:40PM 16/03/2025


•Pt was conscious , oriented and afebrile
•PALLOR- ICTERUS- EDEMA-
•Temperature-98.6 F
•Pulse Rate- 84/min
•BP-110/70 mmHg
• Respiratory rate-16 breaths/min
• Spo2-99% under Room Air
• Chest-B/L VBS, Lungs Clear
• CVS-S1 S2 +, No Murmur

OBSTERTIC EXAMINATION:
• P/A- utts, relaxed, cephalic
• FHR- 134/min
• PV- cervix short, soft, OS admit tip, posterior
• IOV- No active leaking
• USG scan was advised for AFI status
• Urine routine and microscopy done
• High vaginal swab was taken
• TREATMENT-
• Prophylactically
• Inj C+S 1.5 GM IV BD
• Inj PANTOP 40mg IV OD
ON 17/1/2025, 9:45AM:
•Pt was conscious and oriented
•P- I- E-
•Temp- 98.6F
•BP- 110/70 mm Hg
•PR- 86/min
•Chest- B/L VBS heard, Lungs Clear
•CVS- S1 S2+, No Murmur
•P/A-utts, cephalic
•FHR-150/min
•PV-cervix short , soft . OS closed
•Pt was planned for LSCS with indication of PROM>24 hrs associated with CPD
OT NOTE:
•On 17/03/2025 at 10:00 am she underwent LSCS under spinal anesthesia for PROM> 24 hrs
associated with CPD.
•A term female baby weighing 3300 gms was delivered at 2:27pm , 17/03/2025
•Placenta was removed spontaneously
•Intraop Inj Syntocin 30 IU in 1 RL IV and 10 U IM given prophylactically.
•No PPH

POST OP MEDICATION:
•NPO- 24 HRS INJ TRAMADOL IM BD
•IVF 2 UNIT RL, 2 UNIT NS, 1 UNIT DNS AT 100ML/HR INJ F+P IM SOS
•INJ SYNTO 10U IN 1ST 3 UNIT IV FLUIDS FOLEY’S CATHETRIZATION FOR 3 DAYS
•INJ TRANEXA 1 GM IV TDS FOR 24 HR
•INJ C+S 1.5GM IV BD
•INJ METROGYL 1 BOTTLE IV TDS
•INJ ONDEM 4 MG IV BD
•INJ PANTOP (40) IV OD
IN POSTNATAL WARD AT 3:30 PM:
•Patient had 1 episode of seizure, frothing from mouth was seen
•P- I- E-
•RBS -120mg/dl
•BP-120/80mm Hg
•Spo2- 65% on Room Air
•Chest- B/L VBS, lungs clear
•P/A- soft , ut retracted
•IOV- NAB
•TREATMENT-
• INJ MGSO4 LD GIVEN AS PER PRITCHARD’S REGIMEN
• INJ PHENYTOIN 6 AMP IN 1 UNIT RL AT 30 DROPS/MIN GIVEN
• INJ MIDAZOLAM 1.5 ml IV STAT OVER 5-10 MINS
• ANAESTHESIA CALL GIVEN
• CICU CALL GIVEN- PT SHIFTED TO CICU
PT RECEIVED IN CICU AT 4:30 PM ON 17.03.2025:
•Pt on ETT with MV
•Temp-98.6F
•Spo2- unrecordable
•BP- 149/88 mmHg
•PR- 178/ min
•RR-16/min
•Chest- B/L VBS, lungs clear
•CVS-S1S2+. NO MURMUR
•P/A-soft, uterus contracted
•IOV-NAB
•TREATMENT-
• IVF AT 80-90 ML/HR 1UNIT RL, 1UNIT NS, 1 UNIT 5D
• INJ VECURONIUM 4MG/HR
• INJ LEVERA 1 GM IV STAT
• INJ PANTOPRAZOLE 40MG IV STAT
• INJC+S 1.5GM IV BD FOR 5 DAYS
• INJ METRONIDAZOLE (500GM) IV TDS
• INJ AMIKACIN IV BD
• INJ TRANEXA 1 GM IV TDS
• INJ ONDANSETRON 4MG IV BD
• INJ PCM 1GM IV TDS
• INJ MIDAZOLAM 1.5GM IV SOS
• INJ TRAMADOL 500MG IV SOS
• INJ MGSO4 MD TO BE CONTINUED FOR 24 HRS AT 30ML/KG/HR

CICU NOTE 17/03/25 AT 4:30PM:


• Pt on ventilator
• BP-138/82mm Hg
• PR- 90/ min
• Spo2- 100 under MV
• P/A- soft, nontender
• IOV- NAB
• TREATMENT-
• INJ MGSO4 MD 4HRLY
• INJ ONDEM IV TDS
• INJ TRANEXA IV TDS
• INJ OXYTOCIN
• INJ PANTOP IV OD
• INJC+S IV BD
• INJ METRONIDAZOLE IV TDS
• INJ AMIKACIN (HOLD)
• INJ MIDAZOLAM 1.5 GM IV SOS

• IN CICU 18/3/25, 9:30 AM:


• PT on ventilator
• BP-153/89 mmHg
• PR-130/min
• Spo2-100% under MV
• CVS-S1 S2+, No murmur
• RS-B/L VBS, LUNGS CLEAR
• Pt was unconscious, ongoing seizure
• Pallor-
• Peripheral pulses palpable
• P/A- soft, Bowel Sound +, ut contracted
• TREATMENT-
• MECHANICAL VENTILATION WAS CONTINUED
• INJ MIDAZOLAM 2ML SOS
• INJ MGSO4 MD 4HRLY
• INJ ONDEM IV TDS
• INJ PANTOP IV OD
• INJ C+S 1.5 GM IV BD
• INJ TRANEXA IV TID
• INJ METRON IV TID
• INJ LORAZEPAM 2ML BD
• IN CICU 18/3/25, 2:20PM:
• Pt was on mechanical ventilation
• Pt was unconscious, ongoing seizure
• BP-60/30 mmHg
• PR-111/ min
• CVS- S1 S2+
• RS-B/L VBS+, lungs clear
• SPO2- 100% UNDER MV
• P/A- soft, ut contracted
• TREATMENT-
• INJ MEROPENEM 1V BD
• INJ MIDAZ 2ML SOS
• INJ ONDEM IV BD
• INJ PANTOP IV OD
• IN TRANEXA IV TDS
• INJ LORAZEPAM 2ML BD
• ON 18/3/25 AT 7:00PM
• ETT tube was changed under thiopentone – 250mg IV
• IPPV
• 7nm of ET tube reintroduced
• INJ VECURONIUM 4MG IV STAT
• INJ HYDROCORTISONE 100MG IV STAT
• INJ MIDAZOLAM 2MG IV 8 HRLY
• INJ LEVERA- 500MG IV BD
• INJ CISATRA-0.1 MG/KG/HR
• INJ MEROPENEM 1GM IV BD
• INJ TRANEXA 1GM IV TDS
• INJ PANTOP 1 VIAL IV OD
• INVESTIGATIONS ON 18/3/25:
• LFT-
• S. BILLIRUBIN(T)- 1.1 MG/DL
• [Link](D)-0.5 MG/DL
• SGOT-1229 U/L
• SGPT-422U/L
• ALKALINE PHOSPATASE-244 IU/L
• [Link]-2.5 G/DL
• [Link]-5.6 G/DL
• RFT-
• [Link] ACID-13.1 MG/DL
• SR UREA-35MG/DL
• SR CREATININE-1.2 MG/DL
• SR Na+-142 MMOL/L
• SR K+-3.8 MMOL/L
• TOTAL WBC COUNT-32.99 X 10^3 / UL
• TOTAL RBC COUNT-4.4 X 10^6 / UL
• TOTAL PLATELET COUNT-334 X 10^3 / UL
• IN CICU ON 19/3/25 (9:45 AM):
• Pt on ventilation CMV mode
• RR-16 BREATHS/ MIN
• BP- 68/30 MM HG
• PR 16/MIN
• SPO2-100% UNDER MV
• CVS-S1 S2+ NO MURMUR
• R/S- B/L VBS+
• P/A- SOFT BOWEL SOUNDS HEARD
• I/O- 2100/1100
• TREATMENT-
• INJ PANTOP 40 IV OD
• INJ PCM 1GM IV TDS
• INJ ONDEM 4MG IV BD
• INJ METRONIDAZOLE IV TDS
• INJ AMIKACIN 500MG IV BD
• INJ TRANEXA 500 IV TDS
• INJ TRAMADOL IM SOS
• INJ MIDAZOLAM 2ML IV TDS
• INJ LEVERA 500MG IV BD
• INJ MEROPENEM 1GM IV TDS
• INJ NORAD 16MG(10ML/HR)
• INJ VASOPRESSIN 2 AMP (1.5ML/HR)

• IN CICU 19/3/25 AT 10:00AM:


• Pt on ventilator, not responding to pain
• BP-68/30 MMHG
• PR- 16/ MIN
• P/A- soft, uterus contracted
• I/O-3500/1400
• TREATMENT-
• NPO
• INJ NORAD 2 AMP @ 10ML/HR
• INJ MEROPENEM 2.5 GM IV TDS
• INJ METROGYL 1 BOTTLE TID
• INJ LEVERA 500MG IV BD
• INJ PANTOP IV OD
• INJ TRAMADOL IM BD
• INJ LORAZEPAM IM BD
• INJ H. ALBUMIN 1 BOTTLE STAT
• MGSO4 MD COMPLETED
DT-19/3/2025
11:10 AM • Pt gasping on MV • CPR STARTED
• BP-60/50 mmHg with NORAD@ • INJ ADR 1 AMP IV STAT
30microdrops/min
• PR-16/min
• SPO2- Not recordable
• Chest- B/L AE+
• CVS-muffled
11:20 AM • Pt on MV • CPR CONTINUED
• BP- NOT RECORDABLE • INJ ADR 1 AMP IV STAT
• PR- NOT RECORDABLE
• SPO2- NOT RECORDABLE
• CHEST- B/L AE+
• CVS- MUFFLED HEART SOUNDS
11:35 AM • Pt on ETT • CPR STOPPED
• Bp- NOT RECORDABLE
• PR-NOT RECORDABLE
• SPO2- NOT RECORDABLE
• CHEST- B/L AE+
• CVS-S1 S2 NOT HEARD
• CORNEAL REFLEX ABSENT
• B/L PUPIL FIXED AND DILATED
• Despite all resuscitative measures, patient could
not be revived and the patient was declared
dead at 11:35 am on 19/03/2025
• Admission death interval- 2days 15hours 55min
• Ceasrean delivery death interval- 1day 19hours
• Duration of ICU stay- 1day 21 hours 20minutes

• CAUSE OF DEATH-POST PARTUM ECLAMPSIA


WITH ACUTE FATTY LIVER IN PREGNANCY

You might also like